newsfilter
← Latest News
Business Wire·

Xeris Biopharma Reports First Quarter 2026 Financial Results

Total product revenue increased 43% year-over-year to over $82 million Recorlev net revenue increased 95% year-over-year to $50 million Tightens full-year 2026 total revenue guidance to $380 million to $390